UBS Maintains Neutral on Clorox, Raises Price Target to $105

Benzinga Newsdesk www.benzinga.com Positive 63.8%

Neg 0% Neu 0% Pos 63.8%

UBS analyst Peter Grom maintains Clorox (NYSE:CLX) with a Neutral and raises the price target from $100 to $105.

Comments

No comments yet. Be the first!